Please login to the form below

Vimpat

This page shows the latest Vimpat news and features for those working in and with pharma, biotech and healthcare.

UCB bags FDA approval for epilepsy drug Briviact

Belgium-headquartered UCB is already an established player in epilepsy with drugs such as Vimpat (lacosamide) and Keppra (levetiracetam), which is off-patent in most major markets. ... Vimpat added another 495m.

Latest news

UCB wins European approval for epilepsy drug Briviact

The drug adds to an epilepsy treatment portfolio at UCB currently represented by Vimpat (lacosamide) - with sales of 495m in the first nine months of 2015 - along with Keppra (levetiracetam) which
UCB boosted by core medicines growth

Revenue was boosted by its core product range, with Crohn's disease and psoriatic arthritis treatment Cimzia (certolizumab pegol); epilepsy medicine Vimpat (lacosamide) and Parkinson's disease and restless leg syndrome ... Sales of Vimpat increased by 15%
UCB submits brivaracetam for use in epilepsy

The company has since turned to other drugs in its epilepsy portfolio, including Vimpat (lacosamide). ... At the end of last year UCB announced a partnership with Daiichi Sankyo to bring Vimpat to Japan.
New UCB CEO Jean-Christophe Tellier expands his executive team

Hands new roles to Emmanuel Caeymaex, Bharat Tewarie and Jeff Wren
UCB partners with Daiichi to bring epilepsy drug to Japan

UCB partners with Daiichi to bring epilepsy drug to Japan. Companies partner on expanding market for Vimpat. ... Vimpat is an important drug for UCB as it looks to overcome the loss in revenue due to the loss of patent protection for older anti-epileptic

More from news
Approximately 8 fully matching, plus 14 partially matching documents found.

Latest Intelligence

Pharma deals during November 2013

Certainly the good performances from key products such as Cimzia, Vimpat and Neupro may well appeal to those companies feeling a little pipeline bereft.
VIDEO interview: Neil Weir, UCB

For UCB, this notion is especially important considering its focus on severe diseases, including the recent launches of Cimzia (certolizumab pegol) for rheumatoid arthritis and Crohn's disease; Vimpat (lacosamide) for ... As for the future of the company,
Interview with Roch Doliveux, UCB

It is the same with Vimpat. Peak sales were once 350m; now, estimates are at least 1.2bn. ... Vimpat treats a subset of epilepsy, partial onset seizures. One in three patients has this refractory type of seizure.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Healthcare Communications Account Directors x 2: Salary TBC

Senior Medical Writer: Great salary and benefits

Associate Medical Director: Excellent PTO, bonus and 401k package

Account Manager- Healthcare Advertising: Negotiable

Principal Health Economist - North-West: Negotiable

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Senior Medical Writer (Remote Working): Competitive Salary Offered

Account Director: Excellent benefits

Events Manager – Med Comms – Surrey: Salary TBC

Associate Editorial Director – Med Comms – London: Salary TBC

Account Manager / Account Director: Competative

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Associate Medical Director: Highly Competitive

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Director, Market Access / HEOR - North-West: Negotiable

Medical/ Scientific Director: Salary TBC

Senior Medical Writer: Competitive Salary

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Account Manager / Senior Account Manager: 35, 000-40, 000

Healthcare Advertising Senior Account Manager / AD / Senior AD: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...